account_id none on file
legal_name Vistagen Therapeutics, Inc.
ticker VTGN
cik 1411685
domain vistagen.com
linkedin_company_url https://www.linkedin.com/company/vistagen-therapeutics-inc-?trk=top_nav_home
entry_point_account_id none on file
name Vistagen Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq South San Francisco, CA, United States
sector index/company/sector/health-care/
calls 0 filings 9 executives 9 family 0
why_nownone on file
callsnone on file
filings
Our Board has nominated the following continuing directors for election at our Annual Meeting: Ann M. Cunningham, MBA Independent Director
filing / Jul 31, 2026 / receipt
Jon S. Saxe, J.D., LL.M. Independent Director
filing / Jul 31, 2026 / receipt
Shawn K. Singh, J.D. President, Chief Executive Officer and Director
filing / Jul 31, 2026 / receipt
Douglas J. Williamson, M.D. Independent Director
filing / Jul 31, 2026 / receipt
Nick B. Tressler 53 Chief Financial Officer
filing / Jul 31, 2026 / receipt
Reid G. Adler, J.D. 72 Chief Legal Officer
filing / Jul 31, 2026 / receipt
Angel S. Angelov, M.D., MBA 57 Chief Medical Officer
filing / Jul 31, 2026 / receipt
Elissa Cote 51 Chief Corporate Development and Strategy Officer
filing / Jul 31, 2026 / receipt
Joshua S. Prince, MBA 55 Chief Operating Officer
filing / Jul 31, 2026 / receipt
executives
| Angel S. Angelov, M.D., MBA | Chief Medical Officer | - | receipt |
| Ann M. Cunningham, MBA | Independent Director | - | receipt |
| Douglas J. Williamson, M.D. | Independent Director | - | receipt |
| Elissa Cote | Chief Corporate Development and Strategy Officer | - | receipt |
| Jon S. Saxe, J.D., LL.M. | Independent Director | - | receipt |
| Joshua S. Prince, MBA | Chief Operating Officer | - | receipt |
| Nick B. Tressler | Chief Financial Officer | - | receipt |
| Reid G. Adler | Chief Legal Officer | - | receipt |
| Shawn K. Singh, J.D. | President, Chief Executive Officer and Director | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2025-12-03 | Chief Financial Officer, appointed | sec_8k |
| 2022-11-22 | Chief Medical Officer, departed | sec_8k |
| 2022-05-03 | Chief Legal Officer, appointed | sec_8k |
| 2011-09-12 | Chief Financial Officer, departed | sec_8k |
mcp_package_hint
slug vistagen-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$